ANTIPARASITIC DRUGS USED THE IN TREATMENT OF DEMODICOSIS IN DOGS: 2022 LITERATURE REVIEW


Creative Commons License

Ekinci G., Tüfekçi E., Güneş V., Çitil M., Keleş İ.

Veterinary: Modern Analysis, Finding and Researches, Prof. Dr. Aliye SAĞKAN ÖZTÜRK,Asst. Prof. Dr. Atakan ÖZTÜRK, Editör, LIVRE DE LYON, Lyon, ss.51-92, 2023

  • Yayın Türü: Kitapta Bölüm / Mesleki Kitap
  • Basım Tarihi: 2023
  • Yayınevi: LIVRE DE LYON
  • Basıldığı Şehir: Lyon
  • Sayfa Sayıları: ss.51-92
  • Editörler: Prof. Dr. Aliye SAĞKAN ÖZTÜRK,Asst. Prof. Dr. Atakan ÖZTÜRK, Editör
  • Erciyes Üniversitesi Adresli: Evet

Özet

There is strong evidence that canine demodicosis can be effectively treated with weekly amitraz baths and macrocyclic lactones such milbemycin oxime, ivermectin, and moxidectin. Another class of macrocyclic lactone medications used to treat generalized demodicosis is doramactin. Active components in medication combinations frequently include imidacloprid and moxidectin. There have only lately been a few authorized medicinal products for the treatment of canine demodicosis. Until recently, the number of approved medical products for the treatment of demodicosis in dogs has been quite limited. With the use of antiparasitic medications from the isoxazoline group, recent studies have demonstrated remarkable outcomes in the treatment of canine demodicosis. Afoxolaner, fluralaner, lotilaner, and sarolaner are active ingredients belonging to the isoxazoline group, which are available in the market. There are numerous oral and topical spot-on products containing these isoxazoline compounds. The use of isoxazoline group drugs has become a popular choice in recent years for the treatment of demodicosis due to their ease of use, lower side effects compared to other drugs, and their effectiveness in stubborn cases that do not respond to traditional treatments.